New Advances in the Prevention and Treatment of Neurological Diseases

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".

Deadline for manuscript submissions: 10 November 2024 | Viewed by 2005

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurology, Universitätsklinikum Schleswig-Holstein (UKSH), Kiel, Germany
Interests: neurology; neuroepidemiology; multiple sclerosis

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to address the advances in the prevention and treatment of neurological diseases in the era of personalized medicine. Undoubtedly, the knowledge on neurological diseases has been substantially improved in the last few years, giving space for a more mature discussion about the prevention and treatment of diseases of the nervous system. Clinical decisions also tend to be even more personalized, and the patient's individual characteristics are at the heart of clinical reasoning. In this context, the articles in this Special Issue should provide new perspectives on how we can optimize preventive and therapeutic strategies in patients with neurological diseases. We welcome clinical studies on stroke, movement disorders, dementia, epilepsy, demyelinating diseases, headaches, sleep disorders, infectious diseases of the nervous system and neuromuscular disorders. Works on the following topics are particularly welcome:

  • Molecular and genetic mechanisms of neurological diseases;
  • The use of technological devices in clinical neurology;
  • Real-world evidence of currently available treatments for neurological diseases;
  • Refining the clinical indication of pharmacological and non-pharmacological interventions in neurology;
  • The biopsychosocial context in the prevention and treatment of neurological diseases;
  • End-of-life care for people with neurological diseases.

We look forward to receiving your contribution.

Dr. Bruno Kusznir Vitturi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurological diseases
  • personalized medicine
  • stroke
  • movement disorders
  • dementia
  • epilepsy
  • demyelinating diseases
  • headaches
  • sleep disorders
  • infectious diseases of the nervous system
  • neuromuscular disorders

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

14 pages, 1182 KiB  
Article
Effects of Dry Needling on Active Myofascial Trigger Points and Pain Intensity in Tension-Type Headache: A Randomized Controlled Study
by Sofía Monti-Ballano, Sergio Márquez-Gonzalvo, María Orosia Lucha-López, Loreto Ferrández-Laliena, Lucía Vicente-Pina, Rocío Sánchez-Rodríguez, Héctor José Tricás-Vidal and José Miguel Tricás-Moreno
J. Pers. Med. 2024, 14(4), 332; https://doi.org/10.3390/jpm14040332 - 22 Mar 2024
Viewed by 676
Abstract
Tension-type headache is the most prevalent type of headache and is commonly associated with myofascial pain syndrome and the presence of active myofascial trigger points. This randomized controlled trial aimed to assess the impact of dry needling on the total number of active [...] Read more.
Tension-type headache is the most prevalent type of headache and is commonly associated with myofascial pain syndrome and the presence of active myofascial trigger points. This randomized controlled trial aimed to assess the impact of dry needling on the total number of active trigger points, pain intensity, and perceived clinical change in tension-type headache subjects. Thirty-two subjects were randomly assigned to the control and dry needling groups. The presence of active trigger points in 15 head and neck muscles, the headache intensity, and the perceived clinical change were evaluated. A single dry needling technique was administered at each active trigger point across three sessions. Significant differences were observed in the post-treatment measures favouring the dry needling group, including reductions in the headache intensity scores (p = 0.034) and the total number of active trigger points (p = 0.039). Moreover, significant differences in the perception of clinical change were found between the control and treatment groups (p = 0.000). Dry needling demonstrated positive effects in reducing the number of active trigger points and improving the short-term headache intensity in tension-type headache patients. A single dry needling session applied in the cranio-cervical area resulted in a self-perceived improvement compared to the control subjects. Full article
(This article belongs to the Special Issue New Advances in the Prevention and Treatment of Neurological Diseases)
Show Figures

Graphical abstract

Review

Jump to: Research

13 pages, 1020 KiB  
Review
Analysis of the Factors Intervening in the Prehospital Time in a Stroke Code
by Álvaro Astasio-Picado, Yolanda Cruz Chueca, Miriam López-Sánchez, Rocio Ruiz Lozano, María Teresa González-Chapado and Vanesa Ortega-Trancón
J. Pers. Med. 2023, 13(10), 1519; https://doi.org/10.3390/jpm13101519 - 23 Oct 2023
Viewed by 1040
Abstract
Introduction: Strokes continue to be considered public health problems due to the great social and health impact they entail. They are the second cause of death in the world, with a high incidence and prevalence. They are time-dependent diseases, and more than 80% [...] Read more.
Introduction: Strokes continue to be considered public health problems due to the great social and health impact they entail. They are the second cause of death in the world, with a high incidence and prevalence. They are time-dependent diseases, and more than 80% of cases could be avoidable with greater management of risk factors. Objective: to analyze the factors that influence prehospital time in a stroke code. Assess the population’s knowledge of stroke symptoms and teach them how to act when a case is suspected. Document the continued training of health professionals for the early identification of patients with a suspected stroke. Demonstrate the importance of calling EMS as the first contact to reduce delays in prehospital time in a stroke. Methodology: A bibliographic review was carried out focusing on articles published between December 2014 and August 2023. The following databases were consulted: Pubmed (Medline), Dialnet, Google Scholar, Web of Science (WOS), Scielo, Scopus, and ScienceDirect. Results: After applying the article selection criteria and evaluating the quality of the methodology, a total of 18 articles were obtained. The results affirm that the importance of achieving a reduction in prehospital time is based mainly on knowledge of the symptoms and the use of new technologies. Conclusions: The evidence supports that the prehospital time of action in the stroke code is affected by numerous factors. These factors are determining factors in the time of action to achieve good effectiveness in the treatment of the pathology. Full article
(This article belongs to the Special Issue New Advances in the Prevention and Treatment of Neurological Diseases)
Show Figures

Figure 1

Back to TopTop